Results 191 to 200 of about 82,991 (273)

Predictors and Outcomes of Pharmacological and Electrical Cardioversion for Atrial Fibrillation and Flutter in an Indian Emergency Department: A Retrospective Study

open access: yesJournal of Arrhythmia, Volume 42, Issue 2, April 2026.
In a real‐world emergency department study of atrial fibrillation and flutter, cardioversion restored sinus rhythm in 68% of patients. Electrical cardioversion achieved the highest success, while pharmacological and mixed strategies predicted failure. Complications were infrequent but clinically significant.
Abid M. Sadiq   +3 more
wiley   +1 more source

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK/AKT/GSK‐3β Axis

open access: yesThe Kaohsiung Journal of Medical Sciences, Volume 42, Issue 4, April 2026.
ABSTRACT Sacubitril/valsartan (Sac/Val) has emerged as an effective compound with myocardium‐protective functions in experimental and clinical trials for heart failure. This study investigated the function of Sac/Val in hypertensive heart disease (HHD) and explored the underlying mechanism.
Yan‐Jun Yang, Jiu‐Sheng Li
wiley   +1 more source

Cancer Neuroscience: Innovative Conception and Emerging Strategy of Therapy

open access: yesMedComm, Volume 7, Issue 4, April 2026.
In this review, we summarize nerve–cancer interactions and conclude two additional interactions, “perineural invasion” and “neuro‐microbic‐oncology.” Emphasizing the important role of nerves in tumor progression. The nervous system also contributes to the development of cancer comorbidities such as cancer depression and cognitive dysfunction.
Ting Wang   +5 more
wiley   +1 more source

The Australia and New Zealand Diabetic and Ischaemic Foot Outcomes Study (ANZDIFOS)

open access: yesANZ Journal of Surgery, Volume 96, Issue 4, Page 873-880, April 2026.
ABSTRACT Objective There is limited high‐quality data on the factors that contribute to limb loss in patients with diabetes‐related foot disease (DFD) in New Zealand and Australia. Furthermore, wound, ischaemia and foot infection (WIfI) staging has not been validated in the Australasian cohort.
Odette Hart   +8 more
wiley   +1 more source

Diarrhea induced by angiotensin-converting enzyme inhibitors. [PDF]

open access: yesCan Fam Physician
Ekram R   +4 more
europepmc   +1 more source

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 7, Page 1502-1516, April 2026.
Background and Purpose Novel heart failure (HF) pharmacotherapies, including angiotensin receptor‐neprilysin inhibitor (ARNI) and sodium‐glucose cotransporter 2 inhibitors (SGLT2is), may confer cardiovascular benefits by attenuating myocardial fibrosis. However, direct evidence from human failing myocardial samples is limited.
Dávid Nagy   +10 more
wiley   +1 more source

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR): a randomised controlled trial. [PDF]

open access: yesOpen Heart
Pepine CJ   +14 more
europepmc   +1 more source

Causal Effects of Renin–Angiotensin–Aldosterone System Inhibition on Renal Function in Patients With Chronic Kidney Disease: A Quasi‐Experimental Study

open access: yesClinical and Translational Science, Volume 19, Issue 4, April 2026.
ABSTRACT Renin–angiotensin–aldosterone system inhibitors are widely prescribed for chronic kidney disease, but their causal effect on kidney function remains uncertain. This study investigated the impact of starting renin–angiotensin blockade on renal function in adults with kidney disease.
Tae Ryom Oh   +4 more
wiley   +1 more source

Losartan-induced Angioedema: A Case Report and Review of Literature. [PDF]

open access: yesJ Community Hosp Intern Med Perspect
Tou LC, Nourse A, Cox R, Stanford S.
europepmc   +1 more source

Incremental Prognostic Value of Heart‐Type Fatty Acid Binding Protein in Patients With Light Chain Cardiac Amyloidosis: A Prospective Cohort Study

open access: yesClinical and Translational Science, Volume 19, Issue 4, April 2026.
Baseline heart‐type fatty acid binding protein (H‐FABP) independently predicts all‐cause mortality in patients with light chain cardiac amyloidosis (AL‐CA). Elevated H‐FABP levels (> 9.5 ng/mL) are associated with significantly worse survival and provide incremental prognostic value beyond established staging systems, improving risk stratification as ...
Xinqing Li   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy